Vídeos de câncer de pulmão
621 vídeos de câncer de pulmão de sociedades, congressos e centros de oncologia (0 em português). Lista atualizada em 20/11/2026; abaixo, os mais recentes.
Assistir ao canal Pulmão no OncoTV
Could immunotherapy plus an ADC replace the standard of care in NSCLC?VJOncology · 19/11/2026 · 1:12 · apoio da indústria
Treatment Algorithm 🗣️ on Uncommon EGFR mutations in NSCLC with Dr. Susan ScottOncology Brothers · 15/11/2026 · 1:31 · apoio da indústria
#ELCC27 — Share your research. See what it can startESMO · 11/11/2026 · 1:58
How Patient Advocates Shape Research, Education & Care Across the Lung Cancer ExperienceIASLC · 05/11/2026 · 1:01:23
Beyond the Scan: Predicting Immunotherapy Response With ctDNA in NSCLCTargeted Oncology · 03/11/2026 · 15:24 · apoio da indústria
Insights into the risk of pulmonary infections in patients with CLL treated with targeted agentsVJHemOnc · 26/10/2026 · 5:31 · apoio da indústria
EMR-Based Nudge Improves Molecular Testing in Early-Stage NSCLCASCO Podcasts · 21/10/2026 · 22:07
Dr. Sydney Barned: Thriving With Stage IV Lung Cancer, Thanks to Precision MedicineAACR · 16/09/2026 · 4:48
Single-shot SBRT for lung cancer: A straw man debate - 9/1/26ASTRO · 26/08/2026 · 1:14:07
Attend the NCCN 2026 Lung Cancer Congress in Philadelphia or VirtuallyNCCN · 24/08/2026 · 1:17
Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metas...ecancer · 27/07/2026 · 8:33 · apoio da indústria
First Look at LIBRETTO-432 Results: Dr. Monty Pal on ASCO26 Plenary ResearchASCO · 31/05/2026 · 2:03
Balazs Halmos, MD, Answers the Internet's Questions About Lung CancerOncLive · 30/04/2026 · 14:19 · apoio da indústria
CITADEL: neoadjuvant sacituzumab govitecan and pembrolizumab in NSCLCVJOncology · 19/11/2026 · 4:37 · apoio da indústria
Treatment Algorithm discussion on common EGFR mutations in metastatic NSCLC with Dr. Ben LevyOncology Brothers · 15/11/2026 · 1:37 · apoio da indústria
#ELCC27 — Give your research the conversation it deservesESMO · 11/11/2026 · 2:15
Dr. Clarissa Mathias Looks Ahead to LALCA, IASLC’s 52nd Birthday and Lung Cancer Awareness MonthIASLC · 05/11/2026 · 2:07
Dr Lyudmila Bazhenova: FDA Taletrectinib Label Update in ROS1+ NSCLCTargeted Oncology · 20/10/2026 · 7:01 · apoio da indústria
The risk of pulmonary complications in patients with myelofibrosis in the post-transplant settingVJHemOnc · 16/04/2026 · 2:13 · apoio da indústria
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2ASCO Podcasts · 28/07/2026 · 9:01
052: Riding for Breath: The Power of Advocacy and a Family’s Labor of Love to Defeat Lung CancerAACR · 06/08/2025 · 23:37
Highway to the Danger Zone - SBRT for Lung Cancer - 4/1/26ASTRO · 24/03/2026 · 53:31
You Are Invited to the NCCN 2025 Lung Cancer CongressNCCN · 11/08/2025 · 1:14
Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLCecancer · 16/07/2026 · 5:01 · apoio da indústria
First Look at HARMONi-6 Results: Dr. Monty Pal on ASCO26 Plenary ResearchASCO · 31/05/2026 · 1:59
Drs Lee and Saxena on the Study of PD-L1 Expression in EGFR-Mutated NSCLCOncLive · 24/04/2026 · 1:58 · apoio da indústria
Germline testing and BAP1 mutations predict mesothelioma prognosisVJOncology · 12/11/2026 · 1:13 · apoio da indústria
Management of Uncommon EGFR Mutations in NSCLC: Dr. Susan ScottOncology Brothers · 14/11/2026 · 17:33 · apoio da indústria
Thoracic Tumours: Essentials for Clinicians - Third EditionESMO · 27/03/2026 · 1:38
2026 Cancer Care Team AwardsIASLC · 15/10/2026 · 3:15
Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial AccessTargeted Oncology · 13/10/2026 · 18:27 · apoio da indústria
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1ASCO Podcasts · 24/06/2026 · 13:28
045: Thriving Through Cancer - Chef AJ on Her Lung Cancer JourneyAACR · 16/04/2025 · 36:39
Combating Misinformation with Multisociety Advocacy - The Example of Lung Cancer Screening - 3/15/26ASTRO · 16/03/2026 · 1:18:26
ASCO 2026: Lung cancer roundupecancer · 14/07/2026 · 4:04 · apoio da indústria
Maintenance Lurbinectedin + Atezolizumab Improves Survival Outcomes in ES-SCLC in IMforte TrialASCO · 02/06/2025 · 4:42
Dr Reckamp on the Future Implications of the PRAGMATICA-LUNG Trial in Lung CancerOncLive · 26/07/2025 · 1:50 · apoio da indústria
Promising early-phase trials exploiting MTAP deletion in mesotheliomaVJOncology · 12/11/2026 · 1:23 · apoio da indústria
Management of NSCLC with Common EGFR Mutations: Dr. Ben LevyOncology Brothers · 13/11/2026 · 20:45 · apoio da indústria
#ELCC26 — Innovation meets collaborationESMO · 11/02/2026 · 1:44